EP Patent

EP1781654A1 — Pyrrolo-pyridine kinase modulators

Assigned to SGX Pharmaceuticals Inc · Expires 2007-05-09 · 19y expired

What this patent protects

The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity. (see formula I)

USPTO Abstract

The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity. (see formula I)

Drugs covered by this patent

Zelboraf (vemurafenib) · Hoffmann La Roche

Patent Metadata

Patent number: EP1781654A1
Jurisdiction: EP
Classification: —
Expires: 2007-05-09
Drug substance claim: No
Drug product claim: No
Assignee: SGX Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.